产品名称：L-α-磷脂酰乙醇胺,反式磷脂酰化(鸡蛋)
英文名称：L-α-phosphatidylethanolamine, transphosphatidylated (Egg, Chicken)
别名：Egg Trans PE
英文别名：Egg Trans PE；L-a-Phosphatidylethanolamine Transphosphatidylated (prepared from Egg PC)
规格或纯度：>99%
运输条件：超低温冰袋运输
生化机理
Phosphatidylethanolamine (PE) along with other phospholipids forms the backbone of biological membranes. PE is known to regulate autophagy. The autophagic membranes possesses PE with high degree of unsaturation. Egg yolk PE has high radical scavenging activity owing to antioxidant potential.
CAS编号：383907-63-9
储存温度
-20°C储存
分子量：726.076
分子式：C39H76NO8P
Product IntroductionPhosphatidylethanolamine (PE) is a phospholipid found in all living organisms. The phosphatidylethanolamine (PE) headgroup is a zwitterion, with a negatively charged phosphate group and positively charged free amine group. The egg yolk contains high levels of unsaturated PE which accounts to 83.10%.ApplicationEgg Trans PE is suitable for use:in the preparation of zwitterionic liposome for binding assayas a component in optimized theranostic nanoemulsion (NE) formulationsin the preparation of large unilamellar vesicles (LUVs) for detecting the leakage of intraliposomal carboxyfluorescein caused by anthraquinones
Product IntroductionPhosphatidylethanolamine (PE) is a phospholipid found in all living organisms. The phosphatidylethanolamine (PE) headgroup is a zwitterion, with a negatively charged phosphate group and positively charged free amine group. The egg yolk contains high levels of unsaturated PE which accounts to 83.10%.ApplicationEgg Trans PE is suitable for use:in the preparation of zwitterionic liposome for binding assayas a component in optimized theranostic nanoemulsion (NE) formulationsin the preparation of large unilamellar vesicles (LUVs) for detecting the leakage of intraliposomal carboxyfluorescein caused by anthraquinones
德尔塔生物的产品主要服务于药物靶标发现，先导化合物发现、合成及优化，药物候选化合物发现等新药研发的关键环节。以药物构效和构性关系、药物化合物逆合成分析等理论为指导，公司多年密切跟踪药物化合物的动态，形成以药物分子砌块研发设计、定制化合成、分子结构确证、纯度检测及纯化等为代表的核心技术体系，构筑起种类全、规模大的药物分子砌块产品库，能够满足客户对药物分子砌块的高技术、多品类、微小剂量及多频次需求。
德尔塔生物致力于成为全球药物分子砌块领域的领先企业，实现紧跟医药前沿研发方向，及时开发出结构独特、功能多样的药物分子的类型，快速响应客户对药物分子砌块和科学试剂的多样化需求，助力全球新药研发机构加速新药研发进程或降低新药研发成本。